A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine

NCT00384774 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Lasmiditan
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]